Table of Contents Author Guidelines Submit a Manuscript
Obstetrics and Gynecology International
Volume 2010, Article ID 498574, 5 pages
http://dx.doi.org/10.1155/2010/498574
Clinical Study

Imprinting and Promoter Usage of Insulin-Like Growth Factor II in Twin Discordant Placenta

1Fetal Medicine Center, Department of Obstetrics and Gynecology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China
2Department of Pathology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China
3Department of Obstetrics and Gynecology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China

Received 9 October 2009; Accepted 12 May 2010

Academic Editor: Shi-Wen Jiang

Copyright © 2010 Yan-Min Luo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. C. Fleischer, F. A. Manning, P. Jeanty et al., Sonography in Obstetrics and Gynecology, Principles & Practice, McGraw-Hill, New York, NY, USA, 6th edition, 2001.
  2. V. Y. T. Cheung, A. D. Bocking, and O. P. Dasilva, “Preterm discordant twins: what birth weight difference is significant?” American Journal of Obstetrics and Gynecology, vol. 172, no. 3, pp. 955–959, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. H. R. Yalçin, C. G. Zorlu, A. Lembet, S. Özden, and O. Gökmen, “The significance of birth weight difference in discordant twins: a level to standardize?” Acta Obstetricia et Gynecologica Scandinavica, vol. 77, no. 1, pp. 28–31, 1998. View at Google Scholar · View at Scopus
  4. R. Weksberg, C. Shuman, O. Caluseriu et al., “Discordant KCNQ1OT1 imprinting in sets of monozygotic twins discordant for Beckwith-Wiedemann syndrome,” Human Molecular Genetics, vol. 11, no. 11, pp. 1317–1325, 2002. View at Google Scholar · View at Scopus
  5. M. Constância, M. Hemberger, J. Hughes et al., “Placental-specific IGF-II is a major modulator of placental and fetal growth,” Nature, vol. 417, no. 6892, pp. 945–948, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. S. L. Thompson, G. Konfortova, R. I. Gregory, W. Reik, W. Dean, and R. Feil, “Environmental effects on genomic imprinting in mammals,” Toxicology Letters, vol. 120, no. 1–3, pp. 143–150, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. J. C. Williams, K. W. Brown, M. G. Mott, and N. J. Maitland, “Maternal allele loss in Wilms' tumour,” Lancet, vol. 1, no. 8632, pp. 283–284, 1989. View at Google Scholar · View at Scopus
  8. A. Murrell, S. Heeson, W. N. Cooper et al., “An association between variants in the IGF2 gene and Beckwith-Wiedemann syndrome: interaction between genotype and epigenotype,” Human Molecular Genetics, vol. 13, no. 2, pp. 247–255, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. A. L. Fowden, “The insulin-like growth factors and feto-placental growth,” Placenta, vol. 24, no. 8-9, pp. 803–812, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. J. D. Ravenel, K. W. Broman, E. J. Perlman et al., “Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor,” Journal of the National Cancer Institute, vol. 93, no. 22, pp. 1698–1703, 2001. View at Google Scholar · View at Scopus
  11. R. Bajoria, M. J. Gibson, S. Ward, S. R. Sooranna, J. P. Neilson, and M. Westwood, “Placental regulation of insulin-like growth factor axis in monochorionic twins with chronic twin-twin transfusion syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 7, pp. 3150–3156, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Miceli, A. Tropea, F. Minici et al., “Effects of insulin-like growth factor I and II on prostaglandin synthesis and plasminogen activator activity in human umbilical vein endothelial cells,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 1, pp. 372–378, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Li, H. Cui, B. Sandstedt, H. Nordlinder, E. Larsson, and T. J. Ekström, “Expression levels of the insulin-like growth factor-II gene (IGF2) in the human liver: developmental relationships of the four promoters,” Journal of Endocrinology, vol. 149, no. 1, pp. 117–124, 1996. View at Google Scholar · View at Scopus
  14. X. Li, Z. Nong, C. Ekström et al., “Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma,” Cancer Research, vol. 57, no. 10, pp. 2048–2054, 1997. View at Google Scholar · View at Scopus
  15. T. H. Vu and A. R. Hoffman, “Promoter-specific imprinting of the human insulin-like growth factor-II gene,” Nature, vol. 371, no. 6499, pp. 714–717, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. T. J. Ekstrom, H. Cui, X. Li, and R. Ohlsson, “Promoter-specific IGF2 imprinting status and its plasticity during human liver development,” Development, vol. 121, no. 2, pp. 309–316, 1995. View at Google Scholar · View at Scopus
  17. C.-L. Chen, S.-M. Ip, D. Cheng, L.-C. Wong, and H. Y. S. Ngan, “Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer,” Clinical Cancer Research, vol. 6, no. 2, pp. 474–479, 2000. View at Google Scholar · View at Scopus
  18. S. J. Kim, S. E. Park, C. Lee et al., “Alterations in promoter usage and expression levels of insulin-like growth factor-II and H19 genes in cervical carcinoma exhibiting biallelic expression of IGF-II,” Biochimica et Biophysica Acta, vol. 1586, no. 3, pp. 307–315, 2002. View at Publisher · View at Google Scholar · View at Scopus